Aerie Pharmaceuticals Competitors and Similar CompaniesClear all

Aerie Pharmaceuticals's competitors and similar companies include scPharmaceuticals and Olpha.

	Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.	scPharmaceuticals scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery.	Olpha Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products.
Founding Date	Founding Date 2005	Founding Date 2014	Founding Date 1972
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech healthtech pharma	Tags Healthcare drug development pharma
Locations	Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US	Locations Burlington, US HQ	Locations Olaine, LV HQ
Employees	Employees 3808% increase	Employees 96256% increase	Employees 2,191
Valuation ($)	Valuation ($) 722.2 m	Valuation ($) 221.6 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $194.1m (FY, 2021)	Revenue (est.) $36.3m (FY, 2024)	Revenue (est.) €122.2m (FY, 2020)
Cost of goods	Cost of goods $26.8m (FY, 2021)	Cost of goods $11.4m (FY, 2024)	Cost of goods €44.5m (FY, 2020)
Gross profit	Gross profit N/A	Gross profit $25m (FY, 2024)	Gross profit €80.1m (FY, 2020)
Net income	Net income ($74.8m) (FY, 2021)	Net income ($85.1m) (FY, 2024)	Net income €9.5m (FY, 2020)
Funding
Total funding raised	Total funding raised $ 388.6m	Total funding raised $ 62.5m	Total funding raised N/A